HALEON PLC-ADR (HLN) Fundamental Analysis & Valuation

NYSE:HLNUS4055521003

Current stock price

9.24 USD
-0.06 (-0.65%)
At close:
9.26 USD
+0.02 (+0.22%)
After Hours:

This HLN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

8

1. HLN Profitability Analysis

1.1 Basic Checks

  • In the past year HLN was profitable.
  • HLN had a positive operating cash flow in the past year.
  • In the past 5 years HLN has always been profitable.
  • In the past 5 years HLN always reported a positive cash flow from operatings.
HLN Yearly Net Income VS EBIT VS OCF VS FCFHLN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

1.2 Ratios

  • HLN has a better Return On Assets (5.11%) than 85.86% of its industry peers.
  • HLN has a better Return On Equity (10.15%) than 84.29% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 7.04%, HLN belongs to the top of the industry, outperforming 84.29% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for HLN is significantly below the industry average of 13.10%.
  • The 3 year average ROIC (6.87%) for HLN is below the current ROIC(7.04%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 5.11%
ROE 10.15%
ROIC 7.04%
ROA(3y)4.13%
ROA(5y)3.89%
ROE(3y)8.46%
ROE(5y)7.43%
ROIC(3y)6.87%
ROIC(5y)6.44%
HLN Yearly ROA, ROE, ROICHLN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

1.3 Margins

  • HLN's Profit Margin of 15.11% is amongst the best of the industry. HLN outperforms 88.48% of its industry peers.
  • In the last couple of years the Profit Margin of HLN has grown nicely.
  • HLN has a Operating Margin of 22.78%. This is amongst the best in the industry. HLN outperforms 89.53% of its industry peers.
  • HLN's Operating Margin has been stable in the last couple of years.
  • HLN's Gross Margin of 65.01% is fine compared to the rest of the industry. HLN outperforms 71.20% of its industry peers.
  • HLN's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 22.78%
PM (TTM) 15.11%
GM 65.01%
OM growth 3Y0.53%
OM growth 5Y0.46%
PM growth 3Y15.68%
PM growth 5Y5.48%
GM growth 3Y1.63%
GM growth 5Y1.07%
HLN Yearly Profit, Operating, Gross MarginsHLN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 20 40 60

5

2. HLN Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so HLN is destroying value.
  • Compared to 1 year ago, HLN has less shares outstanding
  • The number of shares outstanding for HLN has been reduced compared to 5 years ago.
  • The debt/assets ratio for HLN has been reduced compared to a year ago.
HLN Yearly Shares OutstandingHLN Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B
HLN Yearly Total Debt VS Total AssetsHLN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

2.2 Solvency

  • An Altman-Z score of 2.41 indicates that HLN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • HLN's Altman-Z score of 2.41 is fine compared to the rest of the industry. HLN outperforms 61.78% of its industry peers.
  • HLN has a debt to FCF ratio of 3.87. This is a good value and a sign of high solvency as HLN would need 3.87 years to pay back of all of its debts.
  • With an excellent Debt to FCF ratio value of 3.87, HLN belongs to the best of the industry, outperforming 87.43% of the companies in the same industry.
  • HLN has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
  • HLN has a Debt to Equity ratio of 0.47. This is in the lower half of the industry: HLN underperforms 66.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.87
Altman-Z 2.41
ROIC/WACC0.84
WACC8.43%
HLN Yearly LT Debt VS Equity VS FCFHLN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.3 Liquidity

  • HLN has a Current Ratio of 0.92. This is a bad value and indicates that HLN is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of HLN (0.92) is worse than 88.48% of its industry peers.
  • A Quick Ratio of 0.71 indicates that HLN may have some problems paying its short term obligations.
  • The Quick ratio of HLN (0.71) is worse than 88.48% of its industry peers.
Industry RankSector Rank
Current Ratio 0.92
Quick Ratio 0.71
HLN Yearly Current Assets VS Current LiabilitesHLN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

3

3. HLN Growth Analysis

3.1 Past

  • HLN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.59%.
  • The Earnings Per Share has been growing by 17.56% on average over the past years. This is quite good.
  • The Revenue has decreased by -0.61% in the past year.
  • The Revenue has been growing slightly by 5.78% on average over the past years.
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%280.16%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-0.29%

3.2 Future

  • The Earnings Per Share is expected to grow by 7.99% on average over the next years.
  • Based on estimates for the next years, HLN will show a small growth in Revenue. The Revenue will grow by 3.00% on average per year.
EPS Next Y6.33%
EPS Next 2Y8.72%
EPS Next 3Y9.09%
EPS Next 5Y7.99%
Revenue Next Year-1.37%
Revenue Next 2Y0.84%
Revenue Next 3Y2.02%
Revenue Next 5Y3%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
HLN Yearly Revenue VS EstimatesHLN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 5B 10B 15B
HLN Yearly EPS VS EstimatesHLN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.1 0.2 0.3 0.4 0.5

6

4. HLN Valuation Analysis

4.1 Price/Earnings Ratio

  • HLN is valuated rather expensively with a Price/Earnings ratio of 18.86.
  • Compared to the rest of the industry, the Price/Earnings ratio of HLN indicates a rather cheap valuation: HLN is cheaper than 83.77% of the companies listed in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 26.54, HLN is valued a bit cheaper.
  • With a Price/Forward Earnings ratio of 16.00, HLN is valued correctly.
  • HLN's Price/Forward Earnings ratio is rather cheap when compared to the industry. HLN is cheaper than 80.10% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of HLN to the average of the S&P500 Index (21.68), we can say HLN is valued slightly cheaper.
Industry RankSector Rank
PE 18.86
Fwd PE 16
HLN Price Earnings VS Forward Price EarningsHLN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of HLN indicates a rather cheap valuation: HLN is cheaper than 83.77% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, HLN is valued cheaper than 87.43% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.7
EV/EBITDA 13.19
HLN Per share dataHLN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HLN does not grow enough to justify the current Price/Earnings ratio.
  • HLN has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.98
PEG (5Y)1.07
EPS Next 2Y8.72%
EPS Next 3Y9.09%

5

5. HLN Dividend Analysis

5.1 Amount

  • HLN has a Yearly Dividend Yield of 2.09%. Purely for dividend investing, there may be better candidates out there.
  • HLN's Dividend Yield is rather good when compared to the industry average which is at 0.73. HLN pays more dividend than 92.67% of the companies in the same industry.
  • HLN's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 2.09%

5.2 History

  • HLN has paid a dividend for at least 10 years, which is a reliable track record.
  • The dividend of HLN decreased in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2
HLN Yearly Dividends per shareHLN Yearly Dividends per shareYearly Dividends per share 2023 2024 2025 2026 0.05 0.1 0.15 0.2

5.3 Sustainability

  • HLN pays out 36.71% of its income as dividend. This is a sustainable payout ratio.
DP36.71%
EPS Next 2Y8.72%
EPS Next 3Y9.09%
HLN Yearly Income VS Free CF VS DividendHLN Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B
HLN Dividend Payout.HLN Dividend Payout, showing the Payout Ratio.HLN Dividend Payout.PayoutRetained Earnings

HLN Fundamentals: All Metrics, Ratios and Statistics

HALEON PLC-ADR

NYSE:HLN (4/30/2026, 4:28:00 PM)

After market: 9.26 +0.02 (+0.22%)

9.24

-0.06 (-0.65%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)04-29
Earnings (Next)N/A
Inst Owners60.66%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap41.11B
Revenue(TTM)11.23B
Net Income(TTM)1.67B
Analysts80
Price Target12.06 (30.52%)
Short Float %0.28%
Short Ratio1.48
Dividend
Industry RankSector Rank
Dividend Yield 2.09%
Yearly Dividend0.19
Dividend Growth(5Y)N/A
DP36.71%
Div Incr Years2
Div Non Decr Years2
Ex-Date04-10
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.73%
Min Revenue beat(2)-3.78%
Max Revenue beat(2)-1.69%
Revenue beat(4)0
Avg Revenue beat(4)-3.44%
Min Revenue beat(4)-4.82%
Max Revenue beat(4)-1.69%
Revenue beat(8)0
Avg Revenue beat(8)-3.28%
Revenue beat(12)1
Avg Revenue beat(12)-2.85%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.05%
PT rev (3m)4.22%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.35%
EPS NY rev (3m)-0.32%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.47%
Revenue NY rev (3m)-1.54%
Valuation
Industry RankSector Rank
PE 18.86
Fwd PE 16
P/S 2.76
P/FCF 13.7
P/OCF 11.55
P/B 1.85
P/tB N/A
EV/EBITDA 13.19
EPS(TTM)0.49
EY5.3%
EPS(NY)0.58
Fwd EY6.25%
FCF(TTM)0.67
FCFY7.3%
OCF(TTM)0.8
OCFY8.66%
SpS3.35
BVpS4.99
TBVpS-2.79
PEG (NY)2.98
PEG (5Y)1.07
Graham Number7.41586 (-19.74%)
Profitability
Industry RankSector Rank
ROA 5.11%
ROE 10.15%
ROCE 9.07%
ROIC 7.04%
ROICexc 7.4%
ROICexgc 256.74%
OM 22.78%
PM (TTM) 15.11%
GM 65.01%
FCFM 20.14%
ROA(3y)4.13%
ROA(5y)3.89%
ROE(3y)8.46%
ROE(5y)7.43%
ROIC(3y)6.87%
ROIC(5y)6.44%
ROICexc(3y)7.38%
ROICexc(5y)6.79%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.85%
ROCE(5y)8.36%
ROICexgc growth 3Y31.03%
ROICexgc growth 5Y32.63%
ROICexc growth 3Y5.68%
ROICexc growth 5Y5.43%
OM growth 3Y0.53%
OM growth 5Y0.46%
PM growth 3Y15.68%
PM growth 5Y5.48%
GM growth 3Y1.63%
GM growth 5Y1.07%
F-Score8
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.87
Debt/EBITDA 2.71
Cap/Depr 114.72%
Cap/Sales 3.74%
Interest Coverage 7.04
Cash Conversion 91.68%
Profit Quality 133.23%
Current Ratio 0.92
Quick Ratio 0.71
Altman-Z 2.41
F-Score8
WACC8.43%
ROIC/WACC0.84
Cap/Depr(3y)107.2%
Cap/Depr(5y)109.42%
Cap/Sales(3y)3.18%
Cap/Sales(5y)3.14%
Profit Quality(3y)146.3%
Profit Quality(5y)135.74%
High Growth Momentum
Growth
EPS 1Y (TTM)6.59%
EPS 3Y1.58%
EPS 5Y17.56%
EPS Q2Q%280.16%
EPS Next Y6.33%
EPS Next 2Y8.72%
EPS Next 3Y9.09%
EPS Next 5Y7.99%
Revenue 1Y (TTM)-0.61%
Revenue growth 3Y5.58%
Revenue growth 5Y5.78%
Sales Q2Q%-0.29%
Revenue Next Year-1.37%
Revenue Next 2Y0.84%
Revenue Next 3Y2.02%
Revenue Next 5Y3%
EBIT growth 1Y-1.26%
EBIT growth 3Y1.06%
EBIT growth 5Y2.67%
EBIT Next Year21.48%
EBIT Next 3Y11.4%
EBIT Next 5Y8.96%
FCF growth 1Y12%
FCF growth 3Y8.58%
FCF growth 5Y15.32%
OCF growth 1Y14.47%
OCF growth 3Y8.49%
OCF growth 5Y13.36%

HALEON PLC-ADR / HLN Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for HALEON PLC-ADR?

ChartMill assigns a fundamental rating of 6 / 10 to HLN.


What is the valuation status of HALEON PLC-ADR (HLN) stock?

ChartMill assigns a valuation rating of 6 / 10 to HALEON PLC-ADR (HLN). This can be considered as Fairly Valued.


Can you provide the profitability details for HALEON PLC-ADR?

HALEON PLC-ADR (HLN) has a profitability rating of 8 / 10.


What is the financial health of HALEON PLC-ADR (HLN) stock?

The financial health rating of HALEON PLC-ADR (HLN) is 5 / 10.


Can you provide the dividend sustainability for HLN stock?

The dividend rating of HALEON PLC-ADR (HLN) is 5 / 10 and the dividend payout ratio is 36.71%.